Digital Sleep Therapy for Older Adults With Cognitive Impairment
Key facts
- Who runs it
- Woolcock Institute of Medical Research
- Where
- Australia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 128 people enrolled
- Started
- 10 Nov 2022
- Ended
- 1 Oct 2025
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- SleepFix mobile application
- Record updated
- 22 December 2025
Who can take part
- Age
- 50 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Aged 50 years and older
- Insomnia Severity Index score ≥10
- Self-reported subjective cognitive impairment as defined as moderate subjective cognitive complaints (i.e. answers YES to have cognitive concerns OR thinking and memory skills are worse than same-age peers on the online screening)
- English speaking
- Access to a smartphone and willingness/proficiency to use a mobile app for healthcare
- Able to give informed online consent
Who cannot take part
- Neurological (e.g. Parkinson's, epilepsy) and major psychiatric disease (e.g. current major depression), dementia, history of cerebrovascular events (stroke, TIA); history of head injury with loss of consciousness > 30mins
- Medical conditions with known effects on cognition and sleep (e.g. cancer with chemotherapy)
- Diagnosed obstructive sleep apnoea, or other sleep disorder including REM Sleep Behaviour Disorder, Restless Legs Syndrome or Narcolepsy
- Self-reported jetlag symptoms due to travel in the last 7 days
- Current illicit substance use or alcohol intake suggestive of a hazardous or harmful pattern
- Shift-work
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to determine the efficacy of digital Behavioural Therapy for Insomnia (dBTi) compared to online sleep health education (control) at reducing insomnia symptom severity (Insomnia Severity Index: ISI) in older adults (50+ years) with subjective cognitive impairment from baseline compared to week 8.
The 2 groups in the trial
- TreatmentTreatment being tested
Participants will be instructed to use SleepFix mobile application for 3 weeks with an optional 3 weeks of additional therapy. Participants will complete daily sleep diary entries (which take less than 1 min) which are used to calculate the sleep window titration. SleepFix incorporates sleep restriction and stimulus control which have been shown to be the most powerful components of cognitive-behavioural therapy for insomnia - CBTi. It has been shown to produce rapid, clinically-meaningful insomnia symptom reduction in a shorter period of time compared with both face-to-face and digital CBTi. SleepFix does not require the user to complete modules and multiple components such as other digital CBTi programs (e.g. Sleepio). Further, it is personalised to the individual's current sleep patterns and requires minimal engagement compared to full CBTi.
Treatment: SleepFix mobile application
- ControlNo study treatment, for comparison
Participants randomised to the control group will gain access to the first Sleep Health Education module immediately following completion of baseline questionnaires. There are 3 modules provided bi-weekly and the information in these modules is presented as a subdomain through the study website. The participant will receive a link to this information as each module is made available. Control participants will have full access to these modules for the duration of the study.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- E-buddy Supported Digital Sleep Therapy for Older Adults With Cognitive Impairment
- Record updated
- 22 December 2025